0.1499USD+49.90%Mkt Cap: 692663 USDP/E: —Last update: 2026-06-01
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap692.66K USD
Enterprise Value-1.13M USD
Revenue (TTM)389.78K USD
Gross Profit-3.08M USD
Net Income (TTM)-5.02M USD
Revenue/Share0.1280 USD
Last Price0.1499 USD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.03
PEG—
EV/EBITDA0.21
EV/Revenue-2.90
P/S1.19
P/B0.31
EPS (TTM)-2.26
EPS (Forward)-3.20
52W Range
0.02004% of range3.170
52W High3.170 USD
52W Low0.0200 USD
Profitability
Gross Margin-573.65%
Oper. Margin-1387.94%
EBITDA Margin0.00%
Profit Margin-935.25%
ROE-261.34%
ROA-187.60%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.95M USD
CapEx (TTM)—
FCF Margin-725.32%
FCF Yield-408.16%
Net Debt-1.59M USD
Net Debt/EBITDA0.29
Balance Sheet
Debt/Equity0.02
Current Ratio3.24
Quick Ratio2.89
Book Value/Sh0.3220 USD
Cash/Share0.4020 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateNov 8, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.62M
Float4.33M
Insiders6.31%
Institutions1.30%
Short Interest
Short Ratio3.3d
Short % Float2.35%
Short % Out.2.24%
Shares Short100.09K
Short (prev mo.)133.45K
Technical
SMA 500.0670 (+123.9%)
SMA 2000.3007 (-50.1%)
Beta0.84
S&P 52W Chg27.94%
Avg Vol (30d)34.65K
Avg Vol (10d)42.23K
Technical Indicators
RSI (14)54.0
MACD0.0181
MACD Signal0.0092
MACD Hist.+0.0089
BB Upper0.1625 USD
BB Middle0.0671 USD
BB Lower-0.0283 USD
BB Width284.29%
ATR (14)0.0274 USD
Vol Ratio (20d)0.00x